• HOME
  • ABOUT US
    Corporate OverviewSciwind CultureManagement TeamInvestors
  • THERAPEUTIC AREAS
    OveriewAbout GLP-1
  • PIPELINE
  • NEWS
    Press ReleaseMedia Coverage
  • JOIN US
    Job OpportunitiesBenefitsTeam Building
  • CONTACT US
  • 中
中
中
  • ABOUT US

    Corporate Overview

    Sciwind Culture

    Management Team

    Investors

  • THERAPEUTIC AREAS

    Overiew

    About GLP-1

  • PIPELINE
  • NEWS

    Press Release

    Media Coverage

  • JOIN US

    Job Opportunities

    Benefits

    Team Building

  • CONTACT US
M O R E
M O R E
M O R E
  • 11

    2019-10

    Dr. Pan Han Invited to Attend China Healthcare Summit of Entrepreneurs, Scientists and Investors

  • 18

    2019-09

    Dr. Pan Invited to Attend Sino-Australian Executive Seminar on Clinical Research

  • 15

    2019-07

    Sciwind Participated in the Establishment of China New Drug Alliance for NASH

11

2019-10

Dr. Pan Han Invited to Attend China Healthcare Summit of Entrepreneurs, Scientists and Investors

18

2019-09

Dr. Pan Invited to Attend Sino-Australian Executive Seminar on Clinical Research

15

2019-07

Sciwind Participated in the Establishment of China New Drug Alliance for NASH

M O R E
M O R E

Follow Sciwind on Wechat

General Affairs:PR@sciwind.com.cn

Cooperation:BD@sciwind.com.cn

Career:HR@sciwind.com.cn

Headquarter:No.57, Kejiyuan Road, Qiangtang New Area, Hangzhou, Zhejiang

R&D Center:No. 6, Rongjing East Street, BDA, Yizhuang, Beijing

HOME

ABOUT US

THERAPEUTIC AREAS

PIPELINE

NEWS

JOIN US

CONTACT US

Copyright©2019 杭州先为达生物科技有限公司

Follow Sciwind on Wechat

General Affairs:PR@sciwind.com.cn

Cooperation:BD@sciwind.com.cn

Career:HR@sciwind.com.cn

Copyright©2019先为达